UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 12 | Issue 10 | October 2025

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 12 Issue 3
March-2025
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2503856


Registration ID:
558040

Page Number

i394-i404

Share This Article


Jetir RMS

Title

A Research Review on “APPLICATION OF NOVEL QBD APPROACH IN ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ANALYSIS OF COENZYME Q10 IN SINGLE AND COMBINED DOSAGE FORMS”

Abstract

Abstract Objective: A HPLC Method development and Validation by using QbD Tools/Approach for Coenzyme Q10 and its Combination. Purpose: In Coenzyme Q10, Q refers to the quinine chemical group and 10 refer to the number of isoprenyl chemical subunit in its tail. In general ubiquinones, the number can be anywhere from 6 to 10. It is very important part of the Electron Transport Chain and participates in aerobic cellular respiration, which produces energy in the form of ATP. A study reported that 95% of the Human body’s energy is produced this way. Therefore, those organs with the higher energy requirements- such as the liver, heart and kidney- have the highest CoQ10 concentrations. Coenzyme Q10 (CoQ10) is a fat soluble, vitamin-like naturally occurring substance. The purpose of this research is to evaluate the recently published evidence on the development and validation of HPLC methods for Coenzyme Q10 using the QbD approach. While a few QbD-based stability-indicating RP-HPLC methods for Coenzyme Q10 have been reported, there are no QbD-based spectroscopic methods or QbD-based methods for Coenzyme Q10 in combination with other drugs. Therefore, it is worth considering the development of a QbD-based analytical method for Coenzyme Q10, both alone and in combination with clomiphene citrate, and applying this method to analyze its research or marketed formulations. Furthermore, a PSAR study indicates that no QbD-based analytical method has been patented for Coenzyme Q10, either alone or in combination with other drugs.

Key Words

Keywords: - Coenzyme Q10 (CoQ10), RP-HPLC, Analytical QbD, Patent Search Analysis Research (PSAR )

Cite This Article

"A Research Review on “APPLICATION OF NOVEL QBD APPROACH IN ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ANALYSIS OF COENZYME Q10 IN SINGLE AND COMBINED DOSAGE FORMS”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.12, Issue 3, page no.i394-i404, March-2025, Available :http://www.jetir.org/papers/JETIR2503856.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Research Review on “APPLICATION OF NOVEL QBD APPROACH IN ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ANALYSIS OF COENZYME Q10 IN SINGLE AND COMBINED DOSAGE FORMS”", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.12, Issue 3, page no. ppi394-i404, March-2025, Available at : http://www.jetir.org/papers/JETIR2503856.pdf

Publication Details

Published Paper ID: JETIR2503856
Registration ID: 558040
Published In: Volume 12 | Issue 3 | Year March-2025
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.44340
Page No: i394-i404
Country: Kutch, Gujarat, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000155

Print This Page

Current Call For Paper

Jetir RMS